|
|
Volumn 11, Issue 6, 2012, Pages 430-
|
|
Deal watch: Shire increases focus on regenerative medicine
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLOOD DISEASE;
CELL REGENERATION;
CLINICAL EFFECTIVENESS;
CLINICAL EVALUATION;
COMPARATIVE EFFECTIVENESS;
CORNEA DISEASE;
ENDOTHELIUM CELL;
HEALTH CARE COST;
HEMODIALYSIS;
HUMAN;
IMMUNOPATHOLOGY;
KIDNEY FAILURE;
PRIORITY JOURNAL;
REGENERATIVE MEDICINE;
SHORT SURVEY;
STEM CELL TRANSPLANTATION;
TREATMENT INDICATION;
TREATMENT OUTCOME;
VASCULAR ACCESS;
CATHETERS, INDWELLING;
DRUG INDUSTRY;
ENDOTHELIUM, VASCULAR;
HUMANS;
KIDNEY FAILURE, CHRONIC;
REGENERATIVE MEDICINE;
RENAL DIALYSIS;
|
|
EID: 84861867722
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3767 Document Type: Short Survey |
|
Times cited : (2)
|
|
References (0)
|
